Feb. 15 (Bloomberg) -- Pronova BioPharma ASA, the Norwegian maker of medicines from fish oil, got 2.28 billion kronor ($393 million) of syndicated loans from three banks.
Nordea Bank AB arranged the multicurrency financing, which includes term loans and a revolving credit line, the bank said in a statement. Money in a revolving credit can be borrowed again once it’s been repaid.
SEB AB and Swedbank AB joined the deal in syndication, according to the statement.
Proceeds of the five-year financing replace existing borrowings maturing in 2012, Lysaker, Norway-based Pronova said Oct. 4 in a statement.
To contact the reporter on this story: Karen Eeuwens in London firstname.lastname@example.org.
To contact the editor responsible for this story: Faris Khan at email@example.com.